A detailed history of Colonial Trust CO / Sc transactions in Moderna, Inc. stock. As of the latest transaction made, Colonial Trust CO / Sc holds 306 shares of MRNA stock, worth $11,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
306
Previous 300 2.0%
Holding current value
$11,276
Previous $35,000 42.86%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $381 - $750
6 Added 2.0%
306 $20,000
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $170 - $230
-2 Reduced 0.66%
300 $31,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $2,293 - $3,446
-33 Reduced 9.85%
302 $30,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $3,374 - $4,431
35 Added 11.67%
335 $34,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $35,514 - $63,012
300 New
300 $53,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.